XORTX Announces Type D Meeting with FDA to be held May 1,
● Type D Meeting Requested to Accelerate XRx-008 Clinical Program ● CALGARY, Alberta, March 14, 2023 (GLOBE NEWSWIRE)
Globe Newswire14-03-2023, 18:05
General Fusion Partners with Canadian Nuclear Laboratories to Advance Commercial Power Plant Design 4-04-2024, 20:00